Beschreibung
The research-based pharmaceutical industry has faced growing challenges in recent years as a result of increased economic and regulatory pressures. Rising health care costs, increasing-price pressure from managed care organizations, international price controls, rapid appearance of generic products (or competition within a therapeutic class) in the market, and more stringent regulatory policies have compelled the research-based pharmaceutical companies to refine and accelerate their drug discovery-development processes. Drug discovery process basically is a patient oriented science, where researchers strive to improve the existing drugs or invent a totally new chemical entity, which should be ideally more potent than any existing drug of a similar category. The development of new drugs with potential therapeutic applications is one of the most complex and difficult process. Millions of capital and man-hours are devoted to the discovery of new therapeutic agents. Intervention of computers at some plausible steps is imperative to bring down the cost and time required in the drug discovery process.
Autorenporträt
Dr. Priyanka Dhiman is working as Assistant. Professor at MM College of Pharmacy Mullana (India). She has done her M. Pharm and Ph.D from M.D.U Rohtak. She has five year research experience. Her working areas of interest are Natural Products, Enzyme Inhibition and Computational Drug Design and have more than 30 publications in reputed journals.
Herstellerkennzeichnung:
BoD - Books on Demand
In de Tarpen 42
22848 Norderstedt
DE
E-Mail: info@bod.de
